XML 62 R54.htm IDEA: XBRL DOCUMENT v3.23.3
Restatement of Current Period (Details) - Schedule of Condensed Consolidated Statement of Cash Flows
$ in Thousands
 3 Months Ended 6 Months Ended
Jun. 30, 2022
USD ($)
Jun. 30, 2022
USD ($)
Previously Reported    
Condensed Cash Flow Statements, Captions [Line Items]    
Net loss attributable to Agrify Corporation $ (93,401) $ (102,283)
Depreciation and amortization   2,193
Impairment on goodwill and intangible assets 69,904 69,904
Amortization of premium on investment securities   1,055
Amortization of debt discount   1,228
Amortization of issuance costs  
Interest on investment securities   (1,247)
Early termination of lease  
Provision for doubtful accounts   8,630
Provision for slow-moving inventory   929
Prepaid and refundable taxes  
Debt issuance costs   2,422
Deferred income taxes   (262)
Compensation in connection with the issuance of stock options   1,893
Non-cash interest (income) expense   (1,010)
Gain on extinguishment of notes payable, net  
Loss from disposal of fixed assets   8
Change in fair value of contingent consideration   (907)
Change in fair value of warrant liabilities  
Income (loss) attributable to non-controlling interests   4
Accounts receivable   (4,305)
Inventory   (20,171)
Prepaid expenses and other current assets   (2,714)
Prepaid and refundable taxes   (16)
Right-of-use assets, net   86
Other non-current assets   (1,514)
Accounts payable   (4,943)
Accrued expenses and other current liabilities   (4,000)
Deferred (expense) revenue, net   (2,560)
Net cash used in operating activities   (57,580)
Purchases of property and equipment   (6,398)
Purchase of securities   (211,030)
Proceeds from the sale of securities   214,449
Issuance of loan receivable   (20,443)
Cash paid for business combination, net of cash acquired   (3,513)
Net cash used in investing activities   (26,935)
Proceeds from issuance of debt and warrants in private placement   65,000
Proceeds from issuance of Common Stock and warrants in private placement, net of fees   25,770
Proceeds from IPO, net of fees  
Proceeds from Secondary public offering, net of fees  
Proceeds from exercise of options   19
Proceeds from exercise of warrants   2
Short-term loan payable   2,513
Repayments of debt   (2,008)
Payments on other finance loans  
Payments on insurance financing loans  
Payments of financing leases   (187)
Net cash provided by financing activities   91,109
Net increase in cash and cash equivalents   6,594
Cash and cash equivalents at the beginning of period   12,014
Cash and cash equivalents at the end of period 18,608 18,608
Cash, cash equivalents, and restricted cash and restricted marketable securities at end of period    
Cash and cash equivalents 18,608 18,608
Restricted cash and restricted marketable securities 30,000 30,000
Total cash, cash equivalents, and restricted cash and restricted marketable securities at the end of period 48,608 48,608
Supplemental disclosures of non-cash investing activities  
Initial fair value of warrants  
Financing prepaid insurance  
Adjustment Warrants    
Condensed Cash Flow Statements, Captions [Line Items]    
Net loss attributable to Agrify Corporation   29,459
Depreciation and amortization  
Impairment on goodwill and intangible assets  
Amortization of premium on investment securities  
Amortization of debt discount   1,507
Amortization of issuance costs   370
Interest on investment securities  
Early termination of lease   26
Provision for doubtful accounts  
Provision for slow-moving inventory  
Prepaid and refundable taxes   (16)
Debt issuance costs   (2,422)
Deferred income taxes  
Compensation in connection with the issuance of stock options  
Non-cash interest (income) expense  
Gain on extinguishment of notes payable, net  
Loss from disposal of fixed assets  
Change in fair value of contingent consideration  
Change in fair value of warrant liabilities   (30,966)
Income (loss) attributable to non-controlling interests  
Accounts receivable  
Inventory  
Prepaid expenses and other current assets   3,499
Prepaid and refundable taxes   16
Right-of-use assets, net   (26)
Other non-current assets   1,514
Accounts payable   2,619
Accrued expenses and other current liabilities   (49)
Deferred (expense) revenue, net   1,558
Net cash used in operating activities   7,089
Purchases of property and equipment   (2,702)
Purchase of securities  
Proceeds from the sale of securities  
Issuance of loan receivable  
Cash paid for business combination, net of cash acquired  
Net cash used in investing activities   (2,702)
Proceeds from issuance of debt and warrants in private placement   (2,595)
Proceeds from issuance of Common Stock and warrants in private placement, net of fees   27
Proceeds from IPO, net of fees  
Proceeds from Secondary public offering, net of fees  
Proceeds from exercise of options  
Proceeds from exercise of warrants  
Short-term loan payable   (2,513)
Repayments of debt   2,008
Payments on other finance loans   (243)
Payments on insurance financing loans   (1,071)
Payments of financing leases  
Net cash provided by financing activities   (4,387)
Cash, cash equivalents, and restricted cash and restricted marketable securities at end of period    
Initial fair value of warrants   40,496
Financing prepaid insurance   1,928
Restated    
Condensed Cash Flow Statements, Captions [Line Items]    
Net loss attributable to Agrify Corporation (74,604) (72,824)
Depreciation and amortization   2,193
Impairment on goodwill and intangible assets 69,904 69,904
Amortization of premium on investment securities   1,055
Amortization of debt discount   2,735
Amortization of issuance costs   370
Interest on investment securities   (1,247)
Early termination of lease   26
Provision for doubtful accounts   8,630
Provision for slow-moving inventory   929
Prepaid and refundable taxes   (16)
Deferred income taxes   (262)
Compensation in connection with the issuance of stock options   1,893
Non-cash interest (income) expense   (1,010)
Gain on extinguishment of notes payable, net  
Loss from disposal of fixed assets   8
Change in fair value of contingent consideration   (907)
Change in fair value of warrant liabilities   (30,966)
Income (loss) attributable to non-controlling interests   4
Accounts receivable   (4,305)
Inventory   (20,171)
Prepaid expenses and other current assets   785
Prepaid and refundable taxes  
Right-of-use assets, net   60
Other non-current assets  
Accounts payable   (2,324)
Accrued expenses and other current liabilities   (4,049)
Deferred (expense) revenue, net   (1,002)
Net cash used in operating activities   (50,491)
Purchases of property and equipment   (9,100)
Purchase of securities   (211,030)
Proceeds from the sale of securities   214,449
Issuance of loan receivable   (20,443)
Cash paid for business combination, net of cash acquired   (3,513)
Net cash used in investing activities   (29,637)
Proceeds from issuance of debt and warrants in private placement   62,405
Proceeds from issuance of Common Stock and warrants in private placement, net of fees   25,797
Proceeds from IPO, net of fees  
Proceeds from Secondary public offering, net of fees  
Proceeds from exercise of options   19
Proceeds from exercise of warrants   2
Short-term loan payable  
Repayments of debt  
Payments on other finance loans   (243)
Payments on insurance financing loans   (1,071)
Payments of financing leases   (187)
Net cash provided by financing activities   86,722
Net increase in cash and cash equivalents   6,594
Cash and cash equivalents at the beginning of period   12,014
Cash and cash equivalents at the end of period 18,608 18,608
Cash, cash equivalents, and restricted cash and restricted marketable securities at end of period    
Cash and cash equivalents 18,608 18,608
Restricted cash and restricted marketable securities 30,000 30,000
Total cash, cash equivalents, and restricted cash and restricted marketable securities at the end of period $ 48,608 48,608
Supplemental disclosures of non-cash investing activities  
Initial fair value of warrants   40,496
Financing prepaid insurance   $ 1,928